The aim of the current study was to establish the quantitative relationship between plasma potassium concentrations and the QT interval of the electrocardiogram in dogs. Furosemide, a potent diuretic, was given at increasing doses (5-60 mg/kg) to five male and five female beagle dogs. Electrocardiogram (ECG) was recorded three times each day, simultaneous to blood sampling for measurement of plasma potassium. Furosemide treatment produced a clear hypokalaemia, which was associated with an increase in QT and corrected QT intervals (QTc) duration. On average, the slopes of the negative linear correlation between potassium plasma levels and QT or QTc were steeper in females than in males. These results show that a decrease in potassium plasma level may explain a concomitant increase in QT duration in a toxicity study in dogs, in particular if potassium values are decreased below 3.3 mmol/L. Correction of QT interval for K þ plasma level has, therefore, been established separately for males and females. A global formula correcting QT for K þ and heart rate simultaneously was established. Hypokalaemia was also associated with changes in the morphology of the T wave recorded in CV5RL, in particular, with a flattening and/or a notching of the wave (appearance of a second peak), biphasic aspect or inversion of polarity. These changes are probably related to an increased heterogeneity of repolarization between different populations of cardiomyocytes. In conclusion, hypokalaemia is quantitatively associated with an increase in QT and QTc duration in dogs. The relationship is apparently stronger for females than for males. A formula may be used to correct QT for potassium plasma level.
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Keywords ECG; QT interval; plasma potassium level; hypokalaemia; dog Imbalance in plasma electrolytes, in particular potassium, is known to affect electrocardiogram (ECG). Potassium plays a key role in electrophysiological phenomena and, in particular, in the repolarization of the ventricular cells (Gadsby et al. 1995) . Hypokalaemia increases the duration of cardiac action potential and, consequently, prolongs QT interval. The inhibition of cardiac repolarization associated with a decrease in extracellular potassium is assumed to be related to faster inactivation of I Kr channels responsible for delayed potassium outflow and consequent inhibition of repolarization currents (Yang & Roden 1996 , Yang et al. 1997 .
In humans, the cardiac effect of hypokalaemia is well documented. Decreases in potassium plasma levels may occur in different pathological states and may be produced by a number of drugs (Singh et al. 1992 , Cohen et al. 2002 . Because of these effects on cardiac electrophysiology, hypokalaemia is a major risk factor for arrhythmia in humans (Solomon 1986 , Whelton & Watson 1986 .
In dogs, evidence that hypokalaemia prolongs QT duration can be found in the literature, and drug-induced marked hypokalaemia has been used to produce an experimental model of torsades de pointes (Weissenburger et al. 1991a , b, Chezalviel-Guilbert et al. 1995 . Moreover, hypokalaemia may occur in toxicity studies in dogs as an effect of the treatment. It is then critical to determine the consequence of this change on the cardiac electrophysiology and, especially, on QT duration. However, the relationship between both parameters has not previously been quantified, and the threshold below which a decrease in potassium may actually affect QT has not been defined. Most of the information currently available is from instrumented or anaesthetized dogs or animals with experimental pathologies (Garan et al. 1988 , Vera et al. 1991 . The objective of this study was, therefore, to estimate the quantitative relationship between plasma potassium concentrations and the QT interval in healthy dogs used in toxicology studies. We have also established how QT could be corrected when potassium is lowered.
Material and methods

Animals
Beagle dogs from Marshall USA, two per sex per group (Group 1) or four per sex per group (Group 2) were used. They were aged 21-27 months and had been acclimatized to our facilities for 12-19 months. On day 1, their mean body weight (7SD) was 11.771.8 kg for males and 8.971.4 kg for females.
The animals were individually housed in kennels (247 Â 122 cm) equipped with an elevated resting board, under standard conditions for toxicology studies performed in our laboratory (temperature: 19721C; relative humidity: 60720%; 12 h artificial lighting/day; 14 air changes/h) and received a certified pelleted commercial diet (UAR 125C2, 400 g for males, 300 g for females) and filtered (0.2 m) tap water ad libitum.
At the end of the experiments, the animals were returned to our pool of dogs.
All the experiments were performed in compliance with French laws on animal experimentation (Decree 2001 -464, 29 May 2001 modifying decree 87-848, 19 October 1987 and Pfizer policy on animal welfare.
Induction of hypokalaemia
Furosemide was dissolved in ultrapure water and administered by gastric intubation in a volume of 1 mL/kg. From days 1 to 8, the animals of Group 1 received the vehicle alone, while animals of Group 2 were dosed daily with furosemide at increasing doses. From days 9 to 12, the animals of Group 1 were treated with a high dose of furosemide, while animals of Group 2 received the vehicle alone, except on day 11 at which they were dosed with furosemide. Details of the treatment are given in Table 1 . Induction of hypokalaemia was, therefore, considered as rapid in Group 1 and progressive in Group 2. In order to compensate for a possible excessive loss of sodium and chloride, the animals had free access to saline.
Clinical observations and body weight recording
Dogs were observed once pre-study and then daily for clinical signs. Food was distributed to dogs after the last blood sample on each day and a semi-quantitative estimate of their food intake was made daily. Body weights were measured before the start of any treatment and on days 1, 8 and 12 of the treatment period. 
ECG recording
ECGs were recorded before study start (day À11) and on each day of the treatment period, before dosing and 1-1.5 h and 3-3.5 h post-dose. The dogs were placed in a hammock and ECG tracings were recorded with a cardioline equipment (Remco, Milan) and analysed by the VECG lab system (EMKA Technologies, Paris, France). The standard bipolar limb leads I, II, III, the augmented unipolar limb leads aVR, aVL, aVF and the precordial leads CV6LL, CV5RL, V10 were recorded. Heart rate (HR) was calculated from lead II and QT was measured by the computer from leads II and CV5RL, over 1 min. Values were verified by an experienced technician blinded to the treatment of the animals. When T wave was found bi-or tri-phasic, the end of the T wave was taken as the point of return to the isoelectric line, which was clearly defined, especially in CV5RL, even when the morphology of the T wave was abnormal. Mean QT interval was calculated for each animal at each time point and used as individual value for further analyses.
Plasma chemistry
Blood was sampled on lithium heparin, immediately after each ECG recording, for measurement of the plasma concentrations of sodium, potassium, chloride, calcium, magnesium, urea and creatinine, using an Olympus 600 clinical chemistry analyser.
Statistical analysis
Several linear relations between plasma potassium concentration (K þ ) and QT interval were investigated for each animal using the repeated measures over time. The statistical significance of each individual slope was tested within the regression analysis. Four regression analyses between QT and K þ concentration were performed for each dog, using the four QT measurements: QT recorded in DII or in CV5RL and the corresponding corrected QT intervals (QTc) in DII or CV5RL. The QT interval was corrected for HR using a formula established in our laboratory (Hanton et al. 2001) .
where QTc and QT are, respectively, the corrected QT and the measured QT. The effect of the sex (or of the type of induction of hypokalaemia) was analysed using a mixed model with sex and K þ concentration within a sex (or within a type of induction) as fixed effects and animal as random effect on intercept and slope. The SAS MIXED procedure was used to perform the analyses. In order to determine if there was an effect of the sex (or of the type of induction), a t-test was used to compare slopes. Tests were performed at the 5% significance level.
Formulas for correcting QT interval for plasma potassium concentration were obtained by two ways, either by correcting QTc for K þ concentration or using a correction with two variables in the same model: HR and plasma K þ concentration. The linear regressions between QTc and K þ concentration, or between QT and both K þ concentration and HR were established using the SAS GLM procedure (SAS/STAT, SAS Institute Inc, SAS OnlineDoc s , Version 8, Cary, NC: SAS Institute Inc, 1999) with animal as random effect. The estimated slopes represent the coefficients of correction for QT interval.
Correlations between HR or QT interval and various electrolyte concentrations (potassium, sodium and calcium) were examined. For each pair of variables and each dog, a Pearson correlation coefficient was computed using all values available for a dog.
Results
Development of hypokalaemia following treatment with furosemide and associated changes in QT
Hypokalaemia developed abruptly in Group 1 when treated with high doses of furosemide between days 9 and 12, and more progressively in Group 2 treated with increasing doses of furosemide between days 1 and 8.
There was a parallel increase in QT and QTc duration in both leads, which was rapid in Group 1 and progressive in Group 2. Mean changes in plasma potassium levels, QT and QTc are illustrated in Figures 1 and 2 .
Furosemide treatment was also associated with an increase in HR (Figure 3 ).
Correlation between potassium plasma levels and QT duration
When plotting values from all dogs together, a clear inverse relationship between potassium plasma level and QT or QTc duration was evident. Overall, a decrease of potassium of 1 mmol/L was associated with hypokalaemia on QT duration was seen in all dogs. However, there was a high individual variability in slopes and coefficients of determination (Tables 2 and 3) .
In some animals, the correlation was very low and on average, the coefficient of determination (r 2 ) was about 0.47, when QTc was considered, indicating that about 50% of the variability of QTc can be explained by the change in potassium plasma level. However, the relationship was statistically significant in 10/12 animals for uncorrected QT, 11/12 animals for QTc calculated from DII and 12/12 animals for QTc calculated from CV5RL. In all dogs, a better correlation was found when QTc rather than uncorrected QT was considered because of the treatment-related increase in HR. In most dogs, a better correlation was also found for QT or QTc recorded in CV5RL lead compared to DII.
There were no differences in the slopes if the induction of hypokalaemia was rapid (Group 1) or progressive (Group 2).
In contrast, steeper slopes were found in females than in males, and the difference was statistically significant (P ¼ 0.043). The cause of this difference is unknown.
The linear regression between QTc in CV5RL and potassium plasma level was, therefore, established separately for males and females.
Males: QTc ¼ À17.6 K þ þ 302.5 Females: QTc ¼ À22.8 K þ þ 305.2
With QTc in ms and K þ in mmol/L.
The coefficient of determination (r 2 ) of these equations was 0.69, indicating that the correlation is better when established on all animals together and when considering the animal as a random effect in the mathematical model.
Calculation of a QT corrected for potassium plasma level
Based on the relationship between QTc in CV5RL and plasma potassium level, the following correction formula was established to normalize QTc at a potassium plasma level corresponding to the mean of our historical range. With QTc and QTc K in ms and K þ in mmol/L. In addition, as QT depends on both HR and plasma potassium levels, a formula taking both factors into account was established.
The multiple linear regression between measured QT in CV5RL, HR and plasma potassium was found to be For males: QT ¼ À17.3 K þ À0.33
HR þ 320.8 For females: QT ¼ À22.7 K þ À0.33
HR þ 324.8
The coefficient of determination (r 2 ) of these equations was 0.77, indicating that the relationship between QT and both HR and K þ simultaneously improved compared with the relationship between QTc and K þ despite the fact that, in this latter relationship, the influence of HR on QT has been eliminated by using a correction formula.
It must be noted that, in these formulae, the slope of the HR component is very close to that used in the formula used for QTc calculation. Moreover, the slope of the K þ component is very close to that found for the relationship between QTc and K þ plasma level. This indicates that both HR and K þ act independently of QT.
From these equations, the following correction formulae were derived:
Effects of plasma potassium on Na þ , K þ and Ca 2 þ on HR and QT The treatment with furosemide produced a decrease in Na þ and an increase in Ca 2 þ . In the group treated with a high dose of furosemide from day 9, the changes developed abruptly. In animals treated with increasing doses, the effects on both electrolytes were progressive and tended to recover on the last days of the study ( Figures  5 and 6 ).
There was a negative correlation between QT and Na þ and a positive correlation between Ca 2 þ and QT. However, the correlation of QT with these electrolytes was lower than that found with K þ . Moreover, there was a positive correlation between Na þ and K þ and a negative correlation between Ca 2 þ and K þ , which may explain the apparent correlation between Na þ or Ca 2 þ and QT (Table 4 ).
The correlations between K þ and the other electrolytes were consistent with the decrease in Na þ and increase in Ca 2 þ that occurred over time and paralleled changes in K þ (Figures 5 and 6) .
The correlations between HR and electrolytes were very low, with a large individual variability (Table 4) . Effects of hypokalaemia on T-wave morphology ECG tracings were examined for the morphology of the T wave in CV5RL. In this lead, the T wave recorded in normal untreated dogs is always positive and formed of a single peak. In animals treated with furosemide, the morphology of the T wave changed with the development of hypokalaemia. The first changes were notching (appearance of a second positive peak) and flattening (decreased amplitude) of the wave. These changes tended to worsen with prolonged treatment and in the most severe cases, the T wave was biphasic (positive followed by negative components), triphasic (2 peaks separated by a trough) or completely inverted (negative component only). There were no clear differences between sexes in the type and severity of T-wave morphological abnormalities.
These changes are illustrated in Figure 6 Parallel decrease in K þ and increase in Ca 2 þ over time, in animals treated with furosemide at high dose between days 9 and 12 (a) or increasing doses between days 1 and 8 (b)
Discussion
Hypokalaemia may have a major effect on cardiac repolarization and QT duration (Surawicz 1995 , Yelamanchi et al. 2001 , and it can be produced by drugs tested in toxicology studies in dogs. It is, therefore, important to evaluate the consequences of this change on the QT interval of the experimental animals. In the current study, we have established a quantitative relationship between plasma potassium concentrations and the QT interval in dogs.
In this experiment, we induced hypokalaemia with a high dose of furosemide, a potent diuretic. There is no indication in the literature that this compound may have a direct action on QT in the dog. Furosemide and related diuretics were found not to affect myocardial potassium exchange and cardiac action potential in the rabbit (Poole-Wilson et al. 1978) . We consider, therefore, that the changes seen in QT were the consequences of the changes in K þ plasma level. However, the treatment was associated with an increase in HR that was possibly compensatory to the fluid loss (Jackson 1996 , Olsen et al. 2000 . Therefore, the influence of K þ level was established on QT corrected for HR (QTc), and HR was introduced as a second variable in establishing the linear relationship.
The data in this study clearly demonstrate the relationship between the plasma concentration in potassium and the duration of QT or QTc interval in beagle dogs. An increase in QT or QTc duration occurred simultaneously with the decrease in plasma potassium level following the effect of a potent diuretic. When plotted together, a clear negative correlation was shown between both parameters. The values of the coefficients of determination indicate that K þ plasma level affects QT or QTc duration but is not the only factor influencing these parameters. Nevertheless, a decrease in potassium plasma level may explain a concomitant increase in QT duration in a toxicity study in dogs, in particular, if potassium values are decreased below 3.3 mmol/L.
Although hypokalaemia has been recognized as a cause of QT prolongation in dogs, most of the experiments were done in experimental conditions completely different from those of the current study, and the quantitative relationship between the plasma level of potassium and QT duration was not established (Weissenburger et al. 1991a) . A number of publications report high values of QT duration in dogs with severe hypokalaemia, but QT values at normal plasma potassium have not been indicated (Weissenburger et al. 1991b) . In an experiment where dogs received an intravenous infusion of salbutamol to produce acute hypokalaemia, a decrease of 0.9 mmol/L of plasma potassium was associated with an increase of QT of 30 ms, occurring 60 min after the start of the infusion (Wahlqvist et al. 1978) . Based on these two experimental points, it is possible to calculate a slope of À33 for the linear relationship between K þ and QT. The slightly higher steepness of this slope, compared with our finding could be explained by the more abrupt induction of hypokalaemia and/or by the inaccuracy of evaluation of a slope based on two experimental points only. In addition, salbutamol may act on QT through another pathway, for example by disturbing the autonomic tone (Hoffman & Lefkowitz 1996) , which is known to affect cardiac repolarization (Shusterman et al. 1999 , Magnano et al. 2002 .
Correction of QT for K þ plasma level may, therefore, be recommended when a compound acts on this electrolyte. QT for K þ and HR simultaneously, using a global formula. This method is simpler, faster and probably more accurate since the total variation of QT explained by the linear relationship with both factors together is much higher than with K þ alone.
The slopes of the effects of either HR or K þ on QT do not vary greatly between the formulae, and there is no strong relationship between HR and K þ , which indicates that both parameters act independently of QT, and confirms the advantage of using a global formula.
The effect of the plasma concentrations of other electrolytes on QT is unclear. There was apparently a positive correlation between Ca 2 þ and QT, indicating that hypocalcaemia would produce QT shortening. The negative correlation between Na þ suggests that hyponatraemia would have a QT prolongation effect similar to that of hypokalaemia. The opposite would have been expected from the literature since Na þ is said to counteract the effects of K þ , and hypocalcaemia causes QT prolongation (Yelamanchi et al. 2001 ). However, Na þ and Ca 2 þ produce electrophysiogical abnormalities only at a concentration well outside the physiological range (Fisch 1973 , Surawicz 1995 ). In the current study, there were mild changes in these electrolytes, and their apparent correlation with QT is probably simply the reflexion of the decrease in Na þ and increase in Ca 2 that parallel the development of the hypokalaemia, as a consequence of the diuretic effect of furosemide.
In humans, hypokalaemia is known to produce typical changes in the T wave, in particular a decreased amplitude and the appearance of a U wave (Surawicz et al. 1957 ). Similar changes have been observed in hypokalaemic dogs (Felkai 1985) . In the current study, hypokalaemia was also associated with a decreased amplitude of the T wave and with morphological changes in tracings recorded in CV5RL. The most characteristic was a notching of the wave, consisting of the appearance of a second peak. When pronounced and associated with a marked flattening of the T wave, it resembles a U wave (Yan & Antzelevitch 1998) . A similar notching of the T wave has been found in humans affected by type 2 long QT syndrome (Lupoglazoff et al. 2001) and was produced by I Kr blockers in in vitro preparation of the perfused wedge of canine ventricle (Yan & Antzelevitch 1998) . A biphasic aspect and inversion of polarity are other changes in the T wave indicating impairment in the repolarization following the development of hypokalaemia. These changes in the morphology of the T wave are probably related to an increased heterogeneity of repolarization between different populations of cardiomyocytes and a subsequent modification of the voltage gradient across the ventricular wall (Shimizu & Antzelevitch 1999) . In isolated cardiac tissues, a decrease in extracellular potassium prolongs the duration of cardiac action potential to a greater extent in the epicardium than in other myocardial layers, which is attributed to a predominant I to current (responsible for transient early outflow of potassium) in the epicardium (Antzelevitch et al. 1991) . Electrophysiological studies in isolated cardiac cells also showed that when extracellular potassium decreases, the slope of phase 2 of the action potential becomes steeper and phase 3 slower, resulting in an increased duration of the action potential. The period of incomplete repolarization tends to be longer in Purkinje fibres than in ventricular cells, resulting in an increased dispersion of repolarization (Vera et al. 1991) .
This study has also allowed us to compare QT values recorded in DII and CV5RL over a wide range of values. The good correlation between values obtained from both leads indicates that either could be used to assess changes in QT duration. However, the better correlation between potassium level and QT recorded in CV5RL, compared with DII values, shows that the former lead gives more accurate results. This is consistent with the findings of a previous study and is explained by a better definition of the end of the T wave and, consequently, lower error in measuring the QT duration in CV5RL (Nahas & Geffray 2004) .
In conclusion, hypokalaemia is quantitatively associated with an increase in QT and QTc duration in dogs. The relationship varies between individuals and is apparently stronger for females than for males.
